A lithium level of 0.8 mEq/L on 900 mg daily is appropriate for long-term maintenance therapy
For maintenance treatment, your current lithium level of 0.8 mEq/L falls within the optimal therapeutic range and your dose of 900 mg daily is appropriate. The FDA-approved target range for long-term control is 0.6-1.2 mEq/L 1, and your level sits comfortably in the middle of this range.
Therapeutic Range Context
Your level is ideal for several reasons:
- The FDA label explicitly states that 0.6-1.2 mEq/L is the desirable range for long-term control, typically achieved with 300 mg three to four times daily 1
- Levels of 0.6-0.8 mEq/L are now generally accepted as optimal for maintenance therapy 2, though some clinicians still favor 0.8-1.2 mEq/L
- Higher maintenance levels (0.8-1.0 mEq/L) improve prophylactic efficacy compared to lower ranges 3, with one study showing levels below 0.8 mEq/L were relatively ineffective at preventing recurrences 4
Safety Considerations
Your current level provides a good safety margin:
- Toxicity risk increases significantly above 1.5 mEq/L 1
- At 0.8 mEq/L, you are well below the toxicity threshold while maintaining therapeutic benefit
- Some patients sensitive to lithium may show toxic signs at 1.0-1.5 mEq/L, so your current level avoids this risk zone 1
Monitoring Requirements
Continue with standard monitoring protocols:
- Serum lithium levels should be checked every 2 months during stable maintenance therapy 1
- Draw blood samples 12 hours after your last dose for accurate interpretation 1
- Monitor renal function (BUN, creatinine), thyroid function, and urinalysis every 3-6 months 5
Important Caveats
- Do not rely solely on serum levels—accurate evaluation requires both clinical assessment and laboratory values 1
- If you're elderly, you may need lower target ranges (0.5-0.8 mEq/L) due to increased sensitivity to adverse effects 3
- Watch for early toxicity signs even at therapeutic levels: diarrhea, vomiting, drowsiness, muscle weakness, or tremor 1
Your 900 mg daily dose achieving a 0.8 mEq/L level represents optimal maintenance therapy that balances efficacy against relapse with safety from toxicity.